Denali Therapeutics Inc. (MUN:4DN)

Revenue

Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	2018
Period Ending	Sep 30, 2023	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	2018
Takeda Collaboration Revenue	-	10.00M	Log In	Log In	Log In	Upgrade
Sanofi Collaboration Revenue	-	25.00M	Log In	Log In	Log In	Upgrade
Biogen Collaboration Revenue	295.79M	295.53M	Log In	Log In	Log In	Upgrade
Revenue (Other)	45.02M	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	340.81M	330.53M	Log In	Log In	Log In	Upgrade